investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Multiplexed in vivo drug screening: Inhibitors of metastatic seeding
Monte Meier Winslow
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Monte Meier Winslow
Stanford University
Stanford, United States
Related projects
Samuel Strober
Radiotherapy as Immunotherapy of Tumors
Pancreas
Radiation Oncology
Walter Gwang-Up Park
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
Pancreas
Pathology
Fengzhi Li
An inhibitor of multiple anti-apoptotic gene products for pancreatic cancer
Pancreas
Qizhi C. Yao
A novel miR-198 replacement therapy for pancreatic cancer
Pancreas
Pathology
Samuel I Gunderson
Preclinical Validation of U1 Adaptors for Suppression of KRAS in Pancreatic Cancer
Pancreas
Jared R Mayers
Investigating Branched Chain Amino Acid Metabolism in Pancreatic Cancer
Pancreas
Maike Sander
A novel mouse model to identify biomarkers of IPMN formation and progression
Pancreas
Pathology
Christopher H Becker
Comprehensive Glycoproteomic Tool Development for Cancer Biomarkers
Pancreas